UPLC-ESI-QTOF/MS and multivariate data analysis for blood plasma and serum metabolomics: effect of experimental artefacts and anticoagulant.
about
Post-acquisition filtering of salt cluster artefacts for LC-MS based human metabolomic studiesThe use of mass spectrometry for analysing metabolite biomarkers in epidemiology: methodological and statistical considerations for application to large numbers of biological samples.Pre-diagnostic metabolite concentrations and prostate cancer risk in 1077 cases and 1077 matched controls in the European Prospective Investigation into Cancer and Nutrition.Effects of pre-analytical processes on blood samples used in metabolomics studies.Metabolic profiling in human exposome studies.Advances in metabolome information retrieval: turning chemistry into biology. Part I: analytical chemistry of the metabolome.A new metabolomics-based strategy for identification of endogenous markers of urine adulteration attempts exemplified for potassium nitrite.Metabolomics and Integrative Omics for the Development of Thai Traditional Medicine.A review of blood sample handling and pre-processing for metabolomics studies.Plasma and Serum Metabolite Association Networks: Comparability within and between Studies Using NMR and MS Profiling.Quantitative bioanalytical validation of fosfomycin in human whole blood with volumetric absorptive microsampling.Determination of Aflatoxin B1-Lysine in Pig Serum and Plasma by Liquid Chromatography-Tandem Mass Spectrometry.Serum and plasma amino acids as markers of prediabetes, insulin resistance, and incident diabetes.Impact of Prolonged Blood Incubation and Extended Serum Storage at Room Temperature on the Human Serum Metabolome.Human plasma stability during handling and storage: impact on NMR metabolomics.Quantification of 18 amino acids in human plasma: application in renal transplant patient plasma by targeted UHPLC-MS/MS.Inter-Laboratory Validation of Method to Determine Residual Enrofloxacin in Chicken Meat.The influence of sample collection methodology and sample preprocessing on the blood metabolic profileInfluence of sample collection tube method, anticoagulant-containing plasma versus serum, on influenza virus hemagglutination inhibition titer and microneutralization titer serological assays
P2860
Q27902273-91220A95-192A-4295-BF71-95B7F5AE5AE2Q30250086-0ABA56F4-7E11-40F4-B687-F3BA55000308Q33872077-310F5728-CE05-4482-AACE-3FAA590FD91EQ35753268-84DF010B-EC01-4BE6-8023-23D8EE274305Q38570003-44F8234C-12FE-4AEE-9420-A04D9DB3EDB9Q38608766-9641F754-87CB-4BF7-BA2C-DF6EFCC4BFA4Q38621081-0E82F0BC-A271-4870-9773-CFBB825E3EF4Q38645656-FAA97545-0FE8-4FD9-8C53-5D545C125B98Q39329687-4FCB3CFD-336D-43B9-8C4A-924224D31231Q40197208-875F2426-D9CB-42FB-BD9A-2EA82169D61EQ40427519-09F4C1DE-1880-41FC-B69E-1F8CFC919DB9Q46445487-23DBF475-3E53-448B-A70D-DFC0C97BA896Q47312518-64FA4194-8A72-4D5D-868C-041499CE5772Q49996935-8C559137-C0E3-43B6-B94E-EF7A4E5F1C16Q51328287-84275A13-067E-48E1-9234-DDEAB1EAC077Q51713097-9DE57580-20D7-4B70-A2E5-064C8451947FQ55500169-D1DD6DA5-09F1-47E1-B60D-FDD2AFCAD6EEQ57012065-B3CDAD40-9C50-4EB5-98F2-5B73645E0DDAQ57020163-0FFD4A39-FD81-43F8-B65E-FD4425898500
P2860
UPLC-ESI-QTOF/MS and multivariate data analysis for blood plasma and serum metabolomics: effect of experimental artefacts and anticoagulant.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
UPLC-ESI-QTOF/MS and multivari ...... l artefacts and anticoagulant.
@ast
UPLC-ESI-QTOF/MS and multivari ...... l artefacts and anticoagulant.
@en
type
label
UPLC-ESI-QTOF/MS and multivari ...... l artefacts and anticoagulant.
@ast
UPLC-ESI-QTOF/MS and multivari ...... l artefacts and anticoagulant.
@en
prefLabel
UPLC-ESI-QTOF/MS and multivari ...... l artefacts and anticoagulant.
@ast
UPLC-ESI-QTOF/MS and multivari ...... l artefacts and anticoagulant.
@en
P1476
UPLC-ESI-QTOF/MS and multivari ...... l artefacts and anticoagulant.
@en
P2093
Thaer Barri
P304
P356
10.1016/J.ACA.2013.01.015
P577
2013-01-18T00:00:00Z